-transparent.png){kind=logo}
Sera against purified VP1, VP2, and VP3 poliovirus capsid polypeptides of type 1 poliovirus were prepared in rabbits. Each serum was demonstrated to be specific for the polypeptide against which it was raised by immunoprecipitation with labeled, individualized capsid polypeptides. One of the anti-VP1 sera had a neutralizing capacity against type 1 poliovirus. It was the only one which reacted in immunoprecipitation with D-antigenic infectious particles.
Related Publications
R Crainic, and
B Blondel, and
F Horaud
December 1983,
Vaccine,
R Crainic, and
B Blondel, and
F Horaud
February 1985,
Proceedings of the National Academy of Sciences of the United States of America,
R Crainic, and
B Blondel, and
F Horaud
July 1983,
Gene,
R Crainic, and
B Blondel, and
F Horaud
December 1982,
Proceedings of the National Academy of Sciences of the United States of America,
R Crainic, and
B Blondel, and
F Horaud
January 1985,
Gene,
R Crainic, and
B Blondel, and
F Horaud
September 1998,
The Journal of general virology,
R Crainic, and
B Blondel, and
F Horaud
January 1983,
The EMBO journal,
R Crainic, and
B Blondel, and
F Horaud
October 1983,
Virology,
R Crainic, and
B Blondel, and
F Horaud
May 1987,
Journal of virology,
R Crainic, and
B Blondel, and
F Horaud
February 1993,
Virology,
